Exploring Aerobic Energy Metabolism in Breast Cancer: A Mutational Profile of Glycolysis and Oxidative Phosphorylation

Energy metabolism is a fundamental aspect of the aggressiveness and invasiveness of breast cancer (BC), the neoplasm that most affects women worldwide. Nonetheless, the impact of genetic somatic mutations on glycolysis and oxidative phosphorylation (OXPHOS) genes in BC remains unclear. To fill these gaps, the mutational profiles of 205 screened genes related to glycolysis and OXPHOS in 968 individuals with BC from The Cancer Genome Atlas (TCGA) project were performed. We carried out analyses to characterize the mutational profile of BC, assess the clonality of tumors, identify somatic mutation co-occurrence, and predict the pathogenicity of these alterations. In total, 408 mutations in 132 genes related to the glycolysis and OXPHOS pathways were detected. The <i>PGK1</i>, <i>PC</i>, <i>PCK1</i>, <i>HK1</i>, <i>DONSON</i>, <i>GPD1</i>, <i>NDUFS1</i>, and <i>FOXRED1</i> genes are also associated with the tumorigenesis process in other types of cancer, as are the genes <i>BRCA1</i>, <i>BRCA2</i>, and <i>HMCN1,</i> which had been previously described as oncogenes in BC, with whom the target genes of this work were associated. Seven mutations were identified and highlighted due to the high pathogenicity, which are present in more than one of our results and are documented in the literature as being correlated with other diseases. These mutations are rs267606829 (<i>FOXRED1</i>), COSV53860306 (<i>HK1</i>), rs201634181 (<i>NDUFS1</i>), rs774052186 (<i>DONSON</i>), rs119103242 (<i>PC</i>), rs1436643226 (<i>PC</i>), and rs104894677 (<i>ETFB</i>). They could be further investigated as potential biomarkers for diagnosis, prognosis, and treatment of BC patients.